Table 20-9.
Quality of Care by Race/Ethnicity and Sex in the GWTG-CAD Program, 2009
| Race/Ethnicity | Sex | ||||
|---|---|---|---|---|---|
| Quality-of-Care Measure | White | Black | Hispanic | Men | Women |
| Aspirin at admission* | 98.0 | 98.2 | 97.9 | 97.9 | 97.5 |
| Aspirin at discharge* | 96.1 | 96.3 | 93.5 | 96.7 | 94.5 |
| β-Blockers at discharge* | 96.0 | 97.0 | 94.2 | 96.4 | 94.5 |
| ACEI at discharge | 62.7 | 68.6 | 68.2 | 65.4 | 59.5 |
| ACEI at discharge for AMI patients | 64.6 | 70.1 | 71.1 | 67.3 | 61.7 |
| ACEI in LVSD patients | 84.8 | 83.1 | 82.4 | 84.4 | 81.6 |
| ACEI/ARB for LVSD patients at discharge* | 93.4 | 93.0 | 93.0 | 92.6 | 92.1 |
| Lipid therapy at discharge | 87.5 | 85.9 | 79.4 | 88.5 | 82.6 |
| Lipid therapy at discharge if LDL >100 mg/dL* | 93.5 | 90.7 | 91.5 | 95.2 | 88.2 |
| Patients with last BP <140/90 mm Hg | 80.6 | 72.8 | 79.8 | 81.6 | 76.9 |
| Smoking cessation counseling* | 98.5 | 98.7 | 99.0 | 98.3 | 98.1 |
| Referral to cardiac rehabilitation for AMI patients | 51.5 | 46.2 | 52.6 | 49.6 | 48.3 |
| Composite quality-of-care measure† | 96.4 | 96.5 | 94.8 | 96.7 | 94.9 |
GWTG-CAD indicates Get With the Guidelines–Coronary Artery Disease; ACEI, angiotensin-converting enzyme inhibitor; AMI inhibitor, acute myocardial infarction; LVSD, left ventricular systolic dysfunction; ARB, angiotensin receptor blocker; LDL, low-density lipoprotein; BP, blood pressure.
Values are percentages.
Indicates the 6 key achievement measures targeted in GWTG-CAD.
The composite quality-of-care measure indicates performance on the provision of several elements of care. It is computed by summing the numerators for each key achievement measure across the population of interest to create a composite numerator (all the care that was given), summing the denominators for each measure to form a composite denominator (all the care that should have been given), and reporting the ratio (the percentage of all the needed care that was given).